ArticleCancer research2011

Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients.

Felix Moltzahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.